However, the data of Immunological Genome Project Consortium (35) showed a very high expression of CXCL2 in thioglycolate induced peritoneal neutrophils, raising the possibility that in the context of CMO, neutrophils could be a major source of this chemokine. The gene discussed is CXCL2; the disease is chronic recurrent multifocal osteomyelitis.